Skip to main content
Log in

Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B)

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Focal cortical dysplasia (FCD) type IIA/B (Taylor type) is a malformation of cortical development characterized by laminar disorganization and dysplastic neurons. FCD IIA and FCD IIB denote subtypes in which balloon cells are absent or present, respectively. The etiology of FCD IIA/B is unknown, but previous studies suggest that its pathogenesis may involve aberrant, mixed neuronal-glial differentiation. To investigate whether aberrant differentiation is a consistent phenotype in FCD IIA/B, we studied a panel of neuronal and glial marker antigens in a series of 15 FCD IIB cases, and 2 FCD IIA cases. Double-labeling immunofluorescence and confocal imaging revealed that different combinations of neuronal and glial antigens were co-expressed by individual cells in all cases of FCD IIA/B, but not in control cases of epilepsy due to other causes. Co-expression of neuronal and glial markers was most common in balloon cells, but was also observed in dysplastic neurons. The relative expression of neuronal and glial antigens varied over a broad range. Microtubule-associated protein 1B, an immature neuronal marker, was more frequently co-expressed with glial antigens than were mature neuronal markers, such as neuronal nuclear antigen. Our results indicate that aberrant neuronal-glial differentiation is a consistent and robust phenotype in FCD IIA/B, and support the hypothesis that developmental defects of neuronal and glial fate specification play an important role in its pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Aronica E, Gorter JA, Jansen GH, Veelen CWM van, Rijen PC van, Ramkema M, Troost D (2003) Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in Taylor-type focal cortical dysplasia. Epilepsia 44:785–795

    Google Scholar 

  2. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB (2001) Classification system for malformations of cortical development: update 2001. Neurology 57:2168–2178

    Google Scholar 

  3. Baschong W, Suetterlin R, Laeng RH (2001) Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy. J Histochem Cytochem 49:1565–1571

    Google Scholar 

  4. Bautista JF, Foldvary-Schaefer N, Bingaman WE, Lüders HO (2003) Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features. Epilepsy Res 55:131–136

    Google Scholar 

  5. Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, Aronica E, Crino PB (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56:478–487

    Google Scholar 

  6. Becker AJ, Urbach H, Scheffler B, Baden T, Normann S, Lahl R, Pannek HW, Tuxhorn I, Elger CE, Schramm J, Wiestler OD, Blümcke I (2002) Focal cortical dysplasia of Taylor’s balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 52:29–37

    Google Scholar 

  7. Boonyapisit K, Najm I, Klem G, Ying Z, Burrier C, LaPresto E, Nair D, Bingaman W, Prayson R, Lüders H (2003) Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations. Epilepsia 44:69–76

    Google Scholar 

  8. Cepeda C, Hurst RS, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, André VM, Vinters HV, Ariano MA, Levine MS, Mathern GW (2003) Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 72:472–486

    Google Scholar 

  9. Chan WY, Xia C-L, Dong D-C, Heizmann CW, Yew DT (2003) Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc Res Tech 60:600–613

    Google Scholar 

  10. Cheng A, Krueger BK, Bambrick LL (1999) MAP5 expression in proliferating neuroblasts. Brain Res Dev Brain Res 113:107–113

    Google Scholar 

  11. Choi BH, Kim RC (1984) Expression of glial fibrillary acidic protein in immature oligodendroglia. Science 223:407–409

    Google Scholar 

  12. Colombo N, Citterio A, Galli C, Tassi L, Lo Russo G, Scialfa G, Spreafico R (2003) Neuroimaging of focal cortical dysplasia: neuropathological correlations. Epileptic Disord 5 (Suppl 2):S67–S72

    Google Scholar 

  13. Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B, Everall I (1999) Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol 98:465–472

    Google Scholar 

  14. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J (1996) Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology. Proc Natl Acad Sci USA 93:14152–14157

    Google Scholar 

  15. Crino PB, Trojanowski JQ, Eberwine J (1997) Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol 93:619–627

    Google Scholar 

  16. Crino PB, Duhaime A-C, Baltuch G, White R (2001) Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 56:906–913

    Google Scholar 

  17. Crino PB, Miyata H, Vinters HV (2002) Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 12:212–233

    Google Scholar 

  18. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV (1992) Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol 84:250–260

    Google Scholar 

  19. Duggal N, Iskander S, Hammond RR (2001) Nestin expression in cortical dysplasia. J Neurosurg 95:459–465

    Google Scholar 

  20. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS (1994) Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol 87:493–503

    Google Scholar 

  21. Farrell MA, DeRosa MJ, Curran JG, Lenard Secor D, Cornford ME, Comair YG, Peacock WJ, Shields WD, Vinters HV (1992) Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 83:246–259

    Google Scholar 

  22. Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blümcke I (2004) CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol 108:272–278

    Google Scholar 

  23. Fischer I, Konola J, Cochary E (1990) Microtubule associated protein (MAP1B) is present in cultured oligodendrocytes and co-localizes with tubulin. J Neurosci Res 27:112–124

    Google Scholar 

  24. Garbelli R, Munari C, De Biasi S, Vitellaro-Zuccarello L, Galli C, Bramerio M, Mai R, Battaglia G, Spreafico R (1999) Taylor’s cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol 9:445–461

    Google Scholar 

  25. Golden JA (1998) Holoprosencephaly: a defect in brain patterning. J Neuropathol Exp Neurol 57:991–999

    Google Scholar 

  26. Gonzalez-Billault C, Jimenez-Mateos EM, Caceres A, Diaz-Nido J, Wandosell F, Avila J (2004) Microtubule-associated protein 1B function during normal development, regeneration, and pathological conditions in the nervous system. J Neurobiol 58:48–59

    Google Scholar 

  27. Grant P, Pant HC (2000) Neurofilament protein synthesis and phosphorylation. J Neurocytol 29:843–872

    Google Scholar 

  28. Haubensak W, Attardo A, Denk W, Huttner WB (2004) Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: A major site of neurogenesis. Proc Natl Acad Sci USA 101:3196–3201

    Google Scholar 

  29. Hevner RF, Lacy JM, Englund C, Born D, Folkerth RD (2003) Co-expression of neuronal and glial markers in focal cortical dysplasia: analysis by double labeling immunofluorescence and confocal microscopy. J Neuropathol Exp Neurol 62:558

    Google Scholar 

  30. Hilbig A, Babb TL, Najm I, Ying Z, Wyllie E, Bingaman W (1999) Focal cortical dysplasia in children. Dev Neurosci 21:271–280

    Google Scholar 

  31. Hirose T, Scheithauer BW, Lopes MBS, Gerber HA, Altermatt HJ, Hukee MJ, VandenBerg SR, Charlesworth JC (1995) Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Acta Neuropathol 90:387–399

    Google Scholar 

  32. Hua Y, Crino PB (2003) Single cell lineage analysis in human focal cortical dysplasia. Cereb Cortex 13:693–699

    Google Scholar 

  33. Kalcheva N, Albala JS, Binder LI, Shafit-Zagardo B (1994) Localization of specific epitopes on human microtubule-associated protein 2. J Neurochem 63:2336–2341

    Google Scholar 

  34. Kendler A, Golden JA (1996) Progenitor cell proliferation outside the ventricular and subventricular zones during human brain development. J Neuropathol Exp Neurol 55:1253–1258

    Google Scholar 

  35. Li Y, Corradetti MN, Inoki K, Guan K-L (2004) TSC2 filling the GAP in the mTOR signaling pathway. Trends Biochem Sci 29:32–38

    Google Scholar 

  36. Marín O, Rubenstein JLR (2001) A long, remarkable journey: tangential migration in the telencephalon. Nat Rev Neurosci 2:780–790

    Google Scholar 

  37. McConnell SK, Kaznowski CE (1991) Cell cycle dependence of laminar determination in developing neocortex. Science 254:282–285

    Google Scholar 

  38. McLendon RE, Bigner DD (1994) Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations. Brain Pathol 4:221–228

    Google Scholar 

  39. Mischel PS, Nguyen LP, Vinters HV (1995) Cerebral cortical dysplasia associated with pediatric epilepsy: review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54:137–153

    Google Scholar 

  40. Miyata H, Chiang ACY, Vinters HV (2004) Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56:510–519

    Google Scholar 

  41. Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S (2002) Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol 104:418–424

    Google Scholar 

  42. Monuki ES, Walsh CA (2001) Mechanisms of cerebral cortical patterning in mice and humans. Nat Neurosci 4 (Suppl):1199–1206

    Google Scholar 

  43. Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116:201–211

    Google Scholar 

  44. Najm IM, Ying J, Babb T, Mohamed A, Hadam J, LaPresto E, Wyllie E, Kotagal P, Bingaman W, Foldvary N, Morris H, Lüders HO (2000) Epileptogenicity correlated with increased N-methyl-d-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41:971–976

    Google Scholar 

  45. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Lüders HO, Prayson R, Spreafico R, Vinters HV (2004) Terminology and classification of the cortical dysplasias. Neurology 62:S2–S8

    Google Scholar 

  46. Park S-H, Pepkowitz SH, Kerfoot C, De Rosa MJ, Poukens V, Wienecke R, DeClue JE, Vinters HV (1997) Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol 94:180–186

    Google Scholar 

  47. Riederer B, Cohen R, Matus A (1986) MAP5: a novel brain microtubule-associated protein under strong developmental regulation. J Neurocytol 15:763–775

    Google Scholar 

  48. Romijn HJ, Uum JFM van, Breedijk I, Emmering J, Radu I, Pool CW (1999) Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J Histochem Cytochem 47:229–235

    Google Scholar 

  49. Rosser AE, Tyers P, Borg M ter, Dunnett SB, Svendsen CN (1997) Co-expression of MAP-2 and GFAP in cells developing from rat EGF responsive precursor cells. Brain Res Dev Brain Res 98:291–295

    Google Scholar 

  50. Sánchez C, Díaz-Nido J, Avila J (2000) Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 61:133–168

    Google Scholar 

  51. Schnell SA, Staines WA, Wessendorf MW (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719–730

    Google Scholar 

  52. Shaw G, Osborn M, Weber K (1986) Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments. Eur J Cell Biol 42:1–9

    Google Scholar 

  53. Sidman RL, Rakic P (1982) Development of the human nervous system. In: Haymaker W, Adams RD (eds) Histology and histopathology of the nervous system. Thomas, Springfield, pp. 3–145

  54. Soucek T, Hölzl G, Bernaschek G, Hengstschläger M (1998) A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 16:2197–2204

    Google Scholar 

  55. Spreafico R, Battaglia G, Arcelli P, Andermann F, Dubeau F, Palmini A, Olivier A, Villemure J-G, Tampieri D, Avanzini G, Avoli M (1998) Cortical dysplasia: an immunocytochemical study of three patients. Neurology 50:27–36

    Google Scholar 

  56. Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T (1984) Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch [B] 45:385–396

    Google Scholar 

  57. Tassi L, Pasquier B, Minotti L, Garbelli R, Kahane P, Benabid AL, Battaglia G, Munari C, Spreafico R (2001) Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients. Epilepsia 42:1112–1123

    Google Scholar 

  58. Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, Cardinale F, Cossu M, Ferrario A, Galli C, Bramerio M, Citterio A, Spreafico R (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125:1719–1732

    Google Scholar 

  59. Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Pschiatry 34:369–387

    Google Scholar 

  60. Taylor JP, Sater R, French J, Baltuch G, Crino PB (2001) Transcription of intermediate filament genes is enhanced in focal cortical dysplasia. Acta Neuropathol 102:141–148

    Google Scholar 

  61. Thom M (2004) Cortical dysplasia. In: Golden JA, Harding BN (eds) Pathology and genetics: developmental neuropathology. ISN Neuropath Press, Basel, pp 61–66

  62. Thom M, Barding BN, Lin W-R, Martinian L, Cross H, Sisodiya SM (2003) Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis. Acta Neuropathol 105:561–569

    Google Scholar 

  63. Urbach H, Scheffler B, Heinrichsmeier T, Oertzen J von, Kral T, Wellmer J, Schramm J, Wiestler OD, Blümcke I (2002) Focal cortical dysplasia of Taylor’s balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 43:33–40

    Google Scholar 

  64. Vinters HV, Fisher RS, Cornford ME, Mah V, Secor DL, De Rosa MJ, Comair YG, Peacock WJ, Shields WD (1992) Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Child’s Nerv Syst 8:8–17

  65. Vinters HV, De Rosa MJ, Farrell MA (1993) Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia 34:772–779

    Google Scholar 

  66. Yamanouchi H, Zhang W, Jay V, Becker LE (1996) Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia. Ann Neurol 39:57–61

    Google Scholar 

  67. Yamanouchi H, Jay V, Otsubo H, Kaga M, Becker LE, Takashima S (1998) Early forms of microtubule-associated protein are strongly expressed in cortical dysplasia. Acta Neuropathol 95:466–470

    Google Scholar 

  68. Yamashita N, Ilg EC, Schäfer BW, Heizmann CW, Kosaka T (1999) Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J Comp Neurol 404:235–257

    Google Scholar 

Download references

Acknowledgements

We thank Dr. Ellsworth C. Alvord, Jr. for critical discussions. We thank Tom Kowalczyk, Neri Dagan, Randy Small, and Keonna Harris for excellent technical assistance. A preliminary report of this work was presented in abstract form [29]. Supported by the C.-M. Shaw Professorship in Investigative Neuropathology (R.F.H.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert F. Hevner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Englund, C., Folkerth, R.D., Born, D. et al. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol 109, 519–533 (2005). https://doi.org/10.1007/s00401-005-1005-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-005-1005-9

Keywords

Navigation